Experimental analysis shows SRSF9 forms condensates that enhance RNA splicing in ovarian cancer, suggesting m6A modification may inhibit this process.
Interaction between SRSF9 and NUMB mRNA is inhibited by m6A modification in ovarian cancer cells.
No takes yet. Share an insight, caveat, or question.
Zuo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: